Five Prime Therapeutics nets $66.7mm via IPO
Protein and antibody drug developer Five Prime Therapeutics Inc. netted $66.7mm in its initial public offering of 5.52mm common shares (including the overallotment) at $13 each. The company had planned to sell 4mm shares between $12 and $14.
Drug Discovery Tools
- Large Molecule
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com